Terry Pearson

Directeur Technique/Scientifique/R&D chez Siscapa Assay Technologies, Inc.

78 ans

Health Technology

Consumer Services

Consumer Non-Durables

Postes actifs de Terry Pearson

Sociétés	Poste	Début	Fin
Science Council of British Columbia	Directeur/Membre du Conseil	01/09/2010	-
CAVA Healthcare, Inc. CAVA Healthcare, Inc. Food: Specialty/CandyConsumer Non-Durables CAVA Healthcare, Inc. operates as a early stage biotechnology company. The company is headquartered in Surrey, Canada.	Directeur/Membre du Conseil	-	-
Siscapa Assay Technologies, Inc. Siscapa Assay Technologies, Inc. BiotechnologyHealth Technology Siscapa Assay Technologies, Inc. provides products and services for precise quantitation of protein biomarkers, drugs, and drug targets using immuno-affinity mass spectrometry. Siscapa assays are used in clinical diagnostics and pharma R&D for particularly demanding applications, and in biomarker panels to characterize changes in health, disease, and treatment in longitudinal user-collected dried blood microsamples. Siscapa immuno-affinity mass spectrometry assays for targeted protein quantitation can be developed more quickly than typical ELISA immunoassays since they require only a single specific antibody and provide absolute target specificity because of the MS detection. Because Siscapa assays do not interact with one another, these assays can be freely assembled in panels for various applications. The American company was founded by N. Leigh Anderson, who has been the CEO since incorporation.	Directeur Technique/Scientifique/R&D	-	-
Eyam Vaccines & Immunotherapeutics Ltd.	Directeur/Membre du Conseil	10/01/2022	-

Sociétés	Poste	Début	Fin
BIOASIS TECHNOLOGIES INC.	Directeur/Membre du Conseil	27/03/2008	21/09/2017
BIOASIS TECHNOLOGIES INC.	Independent Dir/Board Member	27/03/2008	21/09/2017
MARKER THERAPEUTICS, INC.	Directeur/Membre du Conseil	-	05/12/2005
University of British Columbia	Corporate Officer/Principal	-	-
NEVIS BRANDS INC.	Directeur/Membre du Conseil	16/12/2014	-
NEVIS BRANDS INC.	Independent Dir/Board Member	16/12/2014	-
University of Victoria	Corporate Officer/Principal	01/01/1979	-
░░░ ░░░░░ ░░░ ░░░░░░░░░░	░░░░░░░░░░░░░░ ░░░░░░	-	-

University of British Columbia

Doctorate Degree

Internationale

Canada	7
Etats-Unis	5

Opérationnelle

Director/Board Member	7
Independent Dir/Board Member	2
Corporate Officer/Principal	2

Sectorielle

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Entreprise privées	5
The Terry Fox Foundation
Science Council of British Columbia
CAVA Healthcare, Inc. CAVA Healthcare, Inc. Food: Specialty/CandyConsumer Non-Durables CAVA Healthcare, Inc. operates as a early stage biotechnology company. The company is headquartered in Surrey, Canada.	Consumer Non-Durables
Siscapa Assay Technologies, Inc. Siscapa Assay Technologies, Inc. BiotechnologyHealth Technology Siscapa Assay Technologies, Inc. provides products and services for precise quantitation of protein biomarkers, drugs, and drug targets using immuno-affinity mass spectrometry. Siscapa assays are used in clinical diagnostics and pharma R&D for particularly demanding applications, and in biomarker panels to characterize changes in health, disease, and treatment in longitudinal user-collected dried blood microsamples. Siscapa immuno-affinity mass spectrometry assays for targeted protein quantitation can be developed more quickly than typical ELISA immunoassays since they require only a single specific antibody and provide absolute target specificity because of the MS detection. Because Siscapa assays do not interact with one another, these assays can be freely assembled in panels for various applications. The American company was founded by N. Leigh Anderson, who has been the CEO since incorporation.	Health Technology
Eyam Vaccines & Immunotherapeutics Ltd.